Cost-effectiveness of novel first-line treatment regimens for tuberculosis
Owens JP, Fofana MO, Dowdy DW. Cost-effectiveness of novel first-line treatment regimens for tuberculosis. The International Journal Of Tuberculosis And Lung Disease 2013, 17: 590-596. PMID: 23575322, PMCID: PMC3844288, DOI: 10.5588/ijtld.12.0776.Peer-Reviewed Original ResearchConceptsDisability-adjusted life yearsFirst-line treatmentStandard treatmentTotal disability-adjusted life yearsFailure/relapseShort-course regimensFirst-line regimensFirst-line drugsHigher drug costsHealth care perspectiveDrug pricesTB patientsActive tuberculosisNovel regimensPatient cohortDrug costsEqual efficacyRegimensLife yearsCare perspectiveTuberculosisRelapsePatientsTreatmentShort duration